Chitosan, a naturally occurring polysaccharide derived from chitin, has demonstrated significant potential as an antiviral ...

Cells can unleash these responses when they detect foreign molecules, such as the RNA genome of SARS-CoV-2. When a cell discovers a telltale molecule, it raises the alarm, by releasing proteins ...

About Invivyd Invivyd, Inc. (Nasdaq: IVVD) is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, beginning with SARS-CoV-2. Invivyd deploys a ...

The AI drug discoverer’s oral small molecule was able to reduce SARS-CoV levels in the lungs of infected mice and also neutralized other RNA viruses like hepatitis C, norovirus and flu in ...

The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

The catalysis of a ribozyme targeting the RNA sequence of SARS-CoV-2 involves a conformational selection mechanism as revealed by a single-molecule mechanical conformer probing method ...

Detailed price information for Sunshine Biopharma (SBFM-Q) from The Globe and Mail including charting and trades.

JENA, Germany - InflaRx N.V. (NASDAQ:IFRX), a biopharmaceutical company focusing on anti-inflammatory therapeutics, has initiated a public offering of its ordinary shares along with pre-funded ...

UNIGE scientists have developed a groundbreaking technology that creates synthetic molecules mimicking antibodies, potentially revolutionizing disease treatments.

The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant ...